Dicerna Pharmaceuticals, Inc

 Company Summary:
  • Dicerna Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery and development of RNAi-based therapeutics for diseases involving the liver, including rare diseases, chronic liver diseases, cardiovascular diseases, and viral infectious diseases.
Transaction Overview: Significance of the Transaction:
  • The Series C financing permits the Company to expand its specialty contract manufacturing capabilities and broaden existing strategic partnerships with global generics manufacturers
Healthios Role:
  • Healthios served as strategic adviser to Dicerna on the Notes and IPO transactions
  • This transaction highlights Healthios commitment to capital formation for emerging growth companies, our success in completing complex transaction, and our dedication to deep, long-term relationships.